Differentiating agents in the treatment of leukemia and myelodysplastic syndromes.
暂无分享,去创建一个
[1] H. Tilly,et al. Low-dose cytarabine versus intensive chemotherapy in the treatment of acute nonlymphocytic leukemia in the elderly. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] R. Berger,et al. RETINOIC ACID THERAPY FOR PROMYELOCYTIC LEUKAEMIA , 1989, The Lancet.
[3] Zhen-yi Wang,et al. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. , 1988, Haematology and blood transfusion.
[4] A. Ganser,et al. Recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes--a phase-I/II trial. , 1988, Onkologie.
[5] A. Berrebi,et al. Review of clinical and haematological response to low‐dose cytosine arabinoside in acute myeloid leukaemia , 1987, European journal of haematology.
[6] J. Gris,et al. Present results of the treatment of myelodysplastic syndromes with low-dose cytosine arabinoside. Preliminary results of a cooperative protocol (38 patients) and review of the literature. , 1987, Acta haematologica.
[7] A. Ho,et al. Combination of low-dose cytarabine and 13-cis retinoic acid in the treatment of myelodysplastic syndromes. , 1987, Leukemia research.
[8] B. Vogelstein,et al. Differentiation of leukemia cells to polymorphonuclear leukocytes in patients with acute nonlymphocytic leukemia. , 1986, The New England journal of medicine.
[9] K. Cantell,et al. Interferon alpha in the treatment of hairy cell leukemia , 1986, Cancer.
[10] F. Sigaux,et al. Treatment of hairy cell leukemia with recombinant alpha interferon: I. Quantitative study of bone marrow changes during the first months of treatment. , 1986, Blood.
[11] J. Abita,et al. Structure-activity relationships of aromatic retinoids on the differentiation of the human histiocytic lymphoma cell line U-937. , 1986, Leukemia research.
[12] F. Sigaux,et al. Treatment of leukemia with low dose Ara-C: a study of 159 cases. , 1985, Haematology and blood transfusion.
[13] F. Sigaux,et al. Low‐dose cytosine arabinoside treatment for acute nonlymphocytic leukemia in elderly patients , 1985, Cancer.
[14] H. Tilly,et al. Does treatment with ARA-C in low dosage cause differentiation of leukemic cells? , 1983, Blood.
[15] M. Housset,et al. Small doses of ARA‐C in the treatment of acute myeloid leukaemia: differentiation of myeloid leukaemia cells? , 1982, British journal of haematology.